.slides > li:first-child { display: block; } .image__fallback { width: 100vw; display: block !important; max-width: 100vw !important; margin-bottom: 0; } .image__fallback + .hsContainer__image { display: none !important; } .hsContainer { height: auto !important; } .no-js-only { display: inherit !important; } .icon-cart.cart-button { display: none; } .lazyload, .cart_page_image img { opacity: 1; -webkit-filter: blur(0); filter: blur(0); } .bcg .hsContent { background-color: transparent; } .animate_right, .animate_left, .animate_up, .animate_down { opacity: 1; } .flexslider .slides>li { display: block; } .product_section .product_form { opacity: 1; } .multi_select, form .select { display: block !important; } .swatch_options { display: none; }

Pens and prospering as a manufacturer

November 18, 2019

Melbourne, Victoria, Australia

Trajan Scientific and Medical (Trajan) has been featured by @AuManufacturing, highlighting Trajan's ongoing investment into the development of hemaPEN®, and other technologies to address emerging trends in healthcare.

The article outlines Trajan's collaborative approach to R&D, and success in identifying and manufacturing niche technologies for global markets.

Read the full article at @AUManufacturing - Pens and prospering as a manufacturer.

More information
hemaPEN
About us
@AuManufacturing

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.

Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.